Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Pediatr Infect Dis J. 2011 May;30(5):375–378. doi: 10.1097/INF.0b013e318202cbb3

TABLE 1.

Pharmacokinetic Parameters

Subject Age (days) Serum
Creatinine
Clearance
(mL/kg/h)
Vd (mL/kg) Half life
(h)
Kel
(h−1)
AUC0–24
(mg*hr/L)
1 6 1.0 27 785 19.9 0.050 493
2 13 1.3 14 1441 73.4 0.013 350
3 14 0.8 12 1522 91.4 0.010 338*
4 14 0.5 18 1021 39.1 0.025 466
5 19 1.2 9 1081 79.4 0.012 493
6 36 0.5 21 711 23.8 0.042 598
7 55 0.3 23 882 27.2 0.036 506
8 59 0.2 14 1635 81.2 0.012 271
Median 17 0.7 16 1051 56 0.02 479
(IQR) (14–41) (0.4–1.1) (13–21) (858–1461) (26–80) (0.01–0.03) (347–496)
*

Infant 3 was supported by extracorporeal membrane oxygenation.